Organon & Co | Bienes





Bienes Cambio Fecha
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Celltrion KRW 21.08T 530.63B 2025-09
Cspc Pharmaceutical CNY 46B 1.61B 2025-06
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 577.44M 251.37M 2025-09
Divis Laboratories Ltd INR 181.51B 12.19B 2025-09
Gilead Sciences USD 59.02B 490M 2025-12
Glaxosmithkline GBP 82.45B 23.19B 2025-09
Kangmei Pharma CNY 13.68B 38.19M 2025-09
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 66.4M 1.06M 2025-06
Merck USD 129.55B 12.02B 2025-09
Neuren Pharmaceuticals AUD 331.25M 78.46M 2025-06
Novartis USD 107.29B 2.89B 2025-09
Organigram Holdings CAD 562.21M 2.4M 2025-09
Organon & Co USD 13.55B 52M 2025-09
Ovoca Bio EUR 11.41M 3.36M 2022-06
Pharma Mar EUR 341.66M 6.59M 2025-09
Qiagen NV USD 6.3B 257.54M 2025-12
Sartorius EUR 9.61B 413.4M 2025-09
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Tilray USD 2.07B 1.33B 2025-03


Organon & Co Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.